Wegovy injections are FDA approved for adults and children 12 years and older with a body mass index of 30 or more, or patients with additional conditions, such as high cholesterol, hypertension, sleep apnea, type 2 diabetes, heart disease, or other chronic metabolic illnesses, who have body mass index of 27 or more
With new therapies like CagriSema on the horizon, the future of weight management looks brighter than ever
Brand-name Ozempic includes patent protection, large-scale manufacturing costs, marketing expenses, and corporate profit margins that add $800+ to monthly pricing
This product is intended for scientific research in controlled laboratory settings only
Accessed January 22, 2025